Top 5 stories on co-morbidities affecting people with HIV from CROI 2024
Should event-driven PrEP be an option for women?
Nearly two million people in sub-Saharan Africa may have advanced HIV disease
Top 5 HIV treatment stories from CROI 2024
Semaglutide improves fatty liver disease and inflammation in people with HIV
Women with HIV need tailored advice on statins and heart disease risk
Progress in reducing new HIV diagnoses much slower for Black men in the US
The cornerstone of HIV treatment may be losing some of its power: will dolutegravir resistance become a problem?
Ultra-long-acting cabotegravir could be taken three times a year for HIV PrEP and treatment
